Skip to main content

Table 5 Postoperative data

From: Role of modified enhanced recovery after surgery (mERAS) in awake craniotomy performed under monitored anesthesia care (MAC); a single center retrospective study

 

Level

Overall

n = 61

mERAS

n = 23

Control

n = 38

p-value

Pain medication consumption*

     

Day 1

Mean ± SD

11.18 ± 15.98

8.62 ± 14.87

12.73 ± 16.62

0.112

Median (25th, 75th percentile)

7.5 (0, 15)

0 (0, 15)

7.75 (0, 15)

 

Day 2

Mean ± SD

12.93 ± 18.89

14.63 ± 22.89

11.90 ± 16,026

0.783

 

Median (25th, 75th percentile)

0 (0, 22.5)

0 (0, 26.25)

0.8 (0, 21.63)

 

Day 3

Mean ± SD

5.13 ± 12.21

6.59 ± 15.54

4.25 ± 9.79

1.000

 

Median (25th, 75th percentile)

0 (0, 0)

0 (0, 0)

0 (0, 0)

 

N/V

n (%)

Yes

13 (22.81%)

4 (20%)

9 (24.32%)

1.000

Length of stay, days

Mean ± SD

6.53 ± 4.92

7.04 ± 5.58

6.13 ± 4.48

0.827

Median (25th, 75th percentile)

5.5 (3, 8)

6 (3, 8.5)

5 (3, 8)

 

Disposition, n (%)

Home

42 (73.68%)

15 (75%)

27 (72.97%)

0.868

 

Rehab

15 (26.32%)

2 (25%)

10 (27.03%)

 

POCD

After 2 weeks, n (%)

     
 

7 (13.21%)

2 (10.53%)

5 (14.71%)

1.000

POCD

After 3 months,

n (%)

 

3 (10%)

1 (10%)

2 (10%)

1.000

  1. *measured in morphine milligram equivalent; N/V: Nausea/Vomiting; POCD: postoperative cognitive dysfunction